期刊文献+

不同方式治疗舒张压升高为主的原发性高血压的临床疗效

Clinical Efficacy of Different Treatments for Essential Hypertension with Elevated Diastolic Blood Pressure
下载PDF
导出
摘要 目的探究针对舒张压升高为主的原发性高血压病症患者,给予不同治疗措施下的疗效差异。方法纳入90例患者进行调查,所有患者纳入时间自2020年1月-2021年1月,根据治疗措施差异将病症分为对照及观察两组,各45例,对照组给予非洛地平缓释片进行治疗,观察组给予吲达帕胺和苯磺酸氨氯地平进行联合用药治疗,以患者用药后的疗效差异、用药前后的心脏指标以及不良反应作为效果对比标准。结果组间患者的疗效差异对比,观察组总有效率高于对照组(P<0.05);由组间患者在接受治疗前后的心脏指标对比,治疗后观察组各项评分均低于对照组(P<0.05);组间患者不良反应统计:观察组与对照组对比无明显数据差异(P>0.05)。结论通过在对舒张压升高为主的原发性高血压患者治疗中,通过以吲达帕胺和氨氯地平进行联用治疗的效果更高,其效果较硝苯地平对比,针对患者的血压控制作用更高,且不会产生明显的不良影响,值得广泛推广。 Objective To explore the difference in curative effect of different treatments for patients with essential hypertension with elevated diastolic blood pressure.Methods Ninety patients were enrolled for investigation.All patients were enrolled from January 2020 to January 2021.According to differences in treatment measures,they were divided into two groups:control and observation.Each group included 45 patients.The control group was given nitrate.Bendipine sustained-release tablets were used for treatment,and the observation group was given indapamide and amLodipine for combined treatment.The difference in curative effect,cardiac indicators before and after treatment,and adverse reactions were used as the standard for comparison of effects.Results Comparison of the difference in curative effect of patients between groups.The total effective rate of the observation group is higher than that of the control group(P<0.05).From the comparison of the cardiac indicators of the patients before and after treatment,the scores of the observation group were lower than those of the control group after treatment(P<0.05).The adverse reaction statistics of patients between groups:There was no significant data difference between the observation group and the control group(P>0.05).Conclusion In the treatment of essential hypertension patients with elevated diastolic blood pressure,the combined treatment of indapamide and amLodipine has a higher effect,which is more effective than nifedipine.It has a higher blood pressure control effect,and does not produce obvious adverse effects,and is more in line with patients’needs for treatment of diseases,and is worthy of widespread promotion.
作者 陆守彦 LU Shouyan(Sheyang County Linhai Central Health Center,Yancheng,Jiangsu 224351)
出处 《智慧健康》 2022年第2期67-69,73,共4页 Smart Healthcare
关键词 不同方式 舒张压升高 原发性高血压 心脏指标 Different ways Elevated diastolic blood pressure Essential hypertension Cardiac indicators
  • 相关文献

参考文献9

二级参考文献55

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部